INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 45 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -50.0% | 13,057 | -74.3% | 0.00% | – |
| Q2 2022 | $32,000 | -50.0% | 50,832 | -9.0% | 0.00% | – |
| Q1 2022 | $64,000 | -46.2% | 55,829 | +5.4% | 0.00% | – |
| Q4 2021 | $119,000 | -47.3% | 52,969 | -19.8% | 0.00% | – |
| Q3 2021 | $226,000 | -26.4% | 66,069 | -35.7% | 0.00% | – |
| Q2 2021 | $307,000 | -11.3% | 102,711 | -65.3% | 0.00% | – |
| Q3 2020 | $346,000 | -57.2% | 295,795 | -66.9% | 0.00% | – |
| Q2 2020 | $808,000 | -2.7% | 893,321 | -9.8% | 0.00% | – |
| Q1 2020 | $830,000 | -12.7% | 990,585 | 0.0% | 0.00% | – |
| Q4 2019 | $951,000 | -13.9% | 990,585 | -7.5% | 0.00% | – |
| Q3 2019 | $1,104,000 | -42.8% | 1,071,454 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $1,929,000 | -6.0% | 1,071,454 | -1.8% | 0.00% | 0.0% |
| Q1 2019 | $2,052,000 | +58.0% | 1,091,319 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $1,299,000 | -55.0% | 1,101,085 | +3.3% | 0.00% | 0.0% |
| Q3 2018 | $2,889,000 | +62.2% | 1,065,874 | +14.3% | 0.00% | 0.0% |
| Q2 2018 | $1,781,000 | +15.5% | 932,370 | +27.0% | 0.00% | 0.0% |
| Q1 2018 | $1,542,000 | +82.3% | 734,272 | +76.2% | 0.00% | – |
| Q4 2017 | $846,000 | +599.2% | 416,689 | +358.1% | 0.00% | – |
| Q3 2017 | $121,000 | -88.2% | 90,953 | -86.1% | 0.00% | – |
| Q2 2017 | $1,024,000 | -35.5% | 652,481 | +32.7% | 0.00% | -100.0% |
| Q1 2017 | $1,588,000 | -23.9% | 491,667 | +99.0% | 0.00% | 0.0% |
| Q3 2015 | $2,088,000 | -50.6% | 247,069 | -36.0% | 0.00% | -66.7% |
| Q2 2015 | $4,225,000 | -22.6% | 385,937 | -1.2% | 0.00% | 0.0% |
| Q1 2015 | $5,462,000 | -17.2% | 390,650 | 0.0% | 0.00% | -25.0% |
| Q4 2014 | $6,598,000 | +25.8% | 390,650 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $5,243,000 | +1.4% | 390,650 | -3.7% | 0.00% | 0.0% |
| Q2 2014 | $5,169,000 | +16.2% | 405,708 | +8.4% | 0.00% | +33.3% |
| Q1 2014 | $4,449,000 | -14.7% | 374,135 | -1.0% | 0.00% | -25.0% |
| Q4 2013 | $5,217,000 | -22.8% | 377,773 | -2.5% | 0.00% | -33.3% |
| Q3 2013 | $6,759,000 | -17.7% | 387,339 | -23.4% | 0.01% | -25.0% |
| Q2 2013 | $8,217,000 | – | 505,631 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
| Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
| Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
| Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
| Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
| Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |